This study, utilizing bioinformatics and experimental validation, has demonstrated that STA may exert its anti-hepatocellular carcinoma effects through multiple targets and pathways, particularly by regulating STAT3 and FN1. The gene discussed is FN1; the disease is hepatocellular carcinoma.